1. Clinical evaluation of a multitarget fecal immunochemical test‐sDNA test for colorectal cancer screening in a high‐risk population: a prospective, multicenter clinical study
- Author
-
Ye‐Ting Hu, Xiao‐Feng Chen, Chun‐Bao Zhai, Xiao‐Tian Yu, Gang Liu, Zhi‐Guo Xiong, Zi‐Qiang Wang, San‐Jun Cai, Wen‐Cai Li, Xiang‐Xing Kong, Qian Xiao, Cai‐Hua Wang, Zhi‐Hua Tao, Li‐Yun Niu, Jian‐Long Men, Qing Wang, Shao‐Zhong Wei, Jun‐Jie Hu, Ting‐Han Yang, Jun‐Jie Peng, Guo‐Zhong Jiang, Ning Lv, Yi‐You Chen, Shu Zheng, Yan‐Hong Gu, and Ke‐Feng Ding
- Subjects
colorectal cancer ,FIT‐sDNA test ,high‐risk population ,risk triaging modality ,Medicine - Abstract
Abstract Colorectal cancer (CRC) is a major malignancy threatening the health of people in China and screening could be effective for preventing the occurrence and reducing the mortality of CRC. We conducted a multicenter, prospective clinical study which recruited 4,245 high‐risk CRC individuals defined as having positive risk‐adapted scores or fecal immunochemical test (FIT) results, to evaluate the clinical performance of the multitarget fecal immunochemical and stool DNA (FIT‐sDNA) test for CRC screening. Each participant was asked to provide a stool sample prior to bowel preparation, and FIT‐sDNA test and FIT were performed independently of colonoscopy. We found that 186 (4.4%) were confirmed to have CRC, and 375 (8.8%) had advanced precancerous neoplasia among the high CRC risk individuals. The sensitivity of detecting CRC for FIT‐sDNA test was 91.9% (95% CI, 86.8–95.3), compared with 62.4% (95% CI, 54.9–69.3) for FIT (P
- Published
- 2023
- Full Text
- View/download PDF